貝通信(603220.SH)招商證券委派謝丹擔任保薦代表人
格隆匯8月18日丨貝通信(603220.SH)發佈公告,公司於2019年8月15日收到保薦機構招商證券《關於更換保薦代表人的函》。公司首次公開發行股票並上市項目的保薦代表人孫世俊因個人原因離職,為保證持續督導工作的有序進行,招商證券委派謝丹擔任公司的保薦代表人,負責對公司的持續督導相關工作,並按照相關規定出具核查意見。本次保薦代表人變更後,公司首次公開發行股票並上市項目的持續督導保薦代表人為鄭勇和謝丹。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.